These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28079570)

  • 1. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan: Reply.
    Sritara C
    Clin Nucl Med; 2017 Mar; 42(3):241-242. PubMed ID: 28079570
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
    Ahn BC
    Clin Nucl Med; 2017 Mar; 42(3):241. PubMed ID: 27922868
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
    Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
    Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental finding on a SPECT/CT of a retroperitoneal leiomyosarcoma imitating a hiatal hernia in 131I whole-body scan in thyroid cancer evaluation.
    Sainz-Esteban A; de Luis Román D; García-Talavera San Miguel P; Pacheco Sánchez D; González Selma ML; Ruiz Gómez MÁ; Gamazo Laherrán C; Villanueva Curto JG; Olmos García R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):406-7. PubMed ID: 23850374
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with emphasize on the thallium scintigraphy in these subgroups.
    Zakani A; Saghari M; Eftekhari M; Fard-Esfahani A; Fallahi B; Esmaili J; Assadi M
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1215-21. PubMed ID: 22165686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.
    Alzahrani AS; Bakheet S; Al Mandil M; Al-Hajjaj A; Almahfouz A; Al Haj A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5294-300. PubMed ID: 11701695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
    Ozkan E; Aras G; Kucuk NO
    Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetectable thyroglobulin in patients with differentiated thyroid carcinoma and residual radioiodine uptake on a postablation whole-body scan.
    Giovanella L; Suriano S; Ceriani L; Verburg FA
    Clin Nucl Med; 2011 Feb; 36(2):109-12. PubMed ID: 21220971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
    Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
    Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
    Ranade R; Kand P; Basu S
    Nucl Med Commun; 2015 Oct; 36(10):1014-20. PubMed ID: 26049373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of positron emission tomography scanning in patients with radioactive iodine scan-negative, recurrent differentiated thyroid cancer.
    Roberts M; Maghami E; Kandeel F; Yamauchi D; Ellenhorn HL; Ellenhorn JD
    Am Surg; 2007 Oct; 73(10):1052-6. PubMed ID: 17983080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
    Bertagna F; Albano D; Bosio G; Piccardo A; Dib B; Giubbini R
    Curr Radiopharm; 2016; 9(3):228-234. PubMed ID: 27210819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastasis from thyroid cancer diagnosed by I-131 whole-body scan without identifiable lesion in the thyroid.
    Wang J; Liu B; Zhao Z; Kuang A
    Clin Nucl Med; 2011 Nov; 36(11):1033-5. PubMed ID: 21975397
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of patients with thyroglobulin-positive and radioactive iodine whole-body scan-negative differentiated thyroid carcinoma.
    Shinohara S; Kikuchi M; Suehiro A; Kishimoto I; Harada H; Hino M; Ishihara T
    Jpn J Clin Oncol; 2015 May; 45(5):427-32. PubMed ID: 25724214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
    Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.